This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A Phase II Trial to Evaluate the Efficacy of AZD60...
Clinical trial

A Phase II Trial to Evaluate the Efficacy of AZD6094 (HMPL-504) in Patients With Papillary Renal Cell Carcinoma (PRCC)

Read time: 1 mins
Last updated:23rd Apr 2014

This is an open-label, single-arm, multicentre, global, Phase II, study designed to evaluate the efficacy and safety of AZD6094 in patients with PRCC who are treatment naïve or previously treated.

Category Value
Study start date 2014-04-23

View full details